Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on July 15, 2026, Federal Biotech has received US$13.5 million (after deducting Danish withholding tax) from Novo Nordisk for UBT251 injection global phase I clinical milestone payments for overweight or obesity indications.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on July 15, 2026, Federal Biotech has received US$13.5 million (after deducting Danish withholding tax) from Novo Nordisk for UBT251 injection global phase I clinical milestone payments for overweight or obesity indications.